For the past couple of months, the tussle between community health volunteers (CHV) and the Brihanmumbai Municipal Corporation (BMC) has led to a pause of some crucial plans, like the trial for adult Bacille Calmette-Guérin (BCG) vaccines, as the former have been demanding the payment of pending dues and better wages.

As part of this trial study, which was to be conducted in collaboration with the Indian Council of Medical Research (ICMR) and the National Tuberculosis Elimination Program (NTEP), CHVs were supposed to survey 12 wards for targeted intervention in six high-risk groups to prevent the spread of tuberculosis.